全球更年期市場規模、佔有率、成長分析，按應用程式、按最終用戶 - 產業預測，2024-2031年

Global Menopause Market Size, Share, Growth Analysis, By Applications(Screening and Diagnosis), By End User(Hospital, Diagnostic Centres) - Industry Forecast 2024-2031

出版日期: 2024年04月28日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

到2022年，全球更年期市場價值將達到169億美元，從2023年的178億美元成長到2031年的269.7億美元，預測期內（2024-2031年）年複合成長率為5.3%。

女性生育年齡的結束以更年期這個生物學正常過程為標誌。閉經的典型特徵是月經結束，通常在 45 歲至 55 歲之間開始。女性在更年期會經歷各種症狀，包括情緒低落、陰道乾燥、潮熱和盜汗。營養食品和其他目的是幫助控制更年期症狀的產品的市場不斷成長。這些產品包括成藥和處方藥、草藥補充品、維生素、礦物質和其他營養食品。對天然和有機產品的渴望、更年期相關健康疾病的日益流行以及人們對營養食品的健康益處的認知不斷提高，預計將在未來幾年對全球更年期市場做出重大貢獻。此外，許多因素推動更年期市場的發展，包括世界人口的老化、與更年期相關的健康風險意識的增強以及對天然和有機產品日益成長的需求。此外，隨著女性接近更年期，她們對健康管理越來越感興趣，這推動了新產品和服務的創造。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東、非洲地區

競爭格局

前5名企業比較
主要企業市場定位（2023年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Pfizer Inc.
Novo Nordisk A/S
Allergan plc
TherapeuticsMD Inc.
Mylan NV
Teva Pharmaceutical Industries Ltd.
Bayer AG
Merck & Co. Inc.
Johnson & Johnson
GlaxoSmithKline plc
Eli Lilly and Company
Amgen Inc.
AbbVie Inc.
Pfizer Inc.
Novartis International AG
Procter & Gamble Co.
Roche Holding AG
Sanofi SA
Serenity Pharmaceuticals LLC
Mithra Pharmaceuticals SA

簡介目錄

Product Code: SQMIG35I2115

Global Menopause Market was valued at USD 16.9 Billion in 2022 and is poised to grow from USD 17.8 Billion in 2023 to USD 26.97 Billion by 2031, at a CAGR of 5.3% during the forecast period (2024-2031).

The end of a woman's reproductive years is marked by the normal biological process of menopause. It is typified by the end of menstruation and typically affects people between the ages of 45 and 55. Women may have a variety of symptoms throughout menopause, such as mood swings, vaginal dryness, hot flashes, and night sweats. The market for dietary supplements and other goods intended to assist women in managing menopausal symptoms is expanding. These goods include over-the-counter and prescription drugs, as well as herbal supplements, vitamins, minerals, and other dietary supplements. The desire for natural and organic products, increased prevalence of menopause-related health disorders, and growing awareness of the health advantages of nutritional supplements are all likely to fuel considerable growth in the worldwide menopausal market in the upcoming years. A multitude of causes, such as the aging of the world's population, greater awareness of health risks associated to menopause, and an increasing desire for natural and organic products, are also driving the menopause market. Additionally, as menopause approaches, women are growing increasingly involved in overseeing their health and well-being, which is propelling the creation of new goods and services.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Menopause Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Menopause Market Segmental Analysis

Global Menopause Market is segmented based on treatment, and region. Based on treatment, the market is segmented into dietary supplements, OTC pharma products. Further, OTC pharma products is segmented into hormonal and non-hormonal. Based on region, the global Menopause Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Menopause Market

It is projected that the market would present a number of opportunities due to variables like the growth of non-hormonal therapies, customized medicine, and digital health solutions, as well as the tendency toward natural and herbal cures. Non-hormonal treatments are gaining popularity despite hormone replacement therapy (HRT) being the primary treatment for menopause symptoms for a considerable amount of time. There is an opportunity for pharmaceutical companies and medical practitioners to create effective non-hormonal therapies for symptoms such as mood swings, vaginal dryness, and hot flashes. Menopause affects women differently, so there is no one-size-fits-all method of treating it. The menopausal market may present a significant opportunity for individualized care that considers a woman's unique symptoms, medical background, and way of life. Additionally, wearable technology, telemedicine, and other digital health technologies may benefit women going through menopause. Digital health solutions that help women track their symptoms, get advice and support, and connect with medical specialists are an opportunity.

Restraints in the Global Menopause Market

Notwithstanding the market's enormous growth potential, obstacles include safety worries, a lack of knowledge and stigma, legal restrictions, and a dearth of R&D may prevent it from expanding. Women who utilize hormone replacement treatment (HRT) have been reported to have an increased risk of breast cancer, heart disease, and stroke. This has led to concerns about the safety of HRT and an increase in the demand for non-hormonal therapy. Businesses that specialize in hormone-based therapy would find it challenging to resolve these safety concerns. Many nations still view menopause as a taboo topic, and little is known about it or how it impacts women's health. This could lower demand and make it more difficult for companies to effectively market menopause-related products and services. Furthermore, strict regulatory regulations, particularly for hormone-based therapy, govern the menopausal industry. Companies that create new drugs and therapies must meet stringent safety and efficacy standards before receiving a license to be used. But much remains unknown about menopause and its effects on women's health. The dearth of research and development in the field may make effective treatments and therapies more difficult to come by. These are a handful of the factors that may prevent the market from growing.

Market Trends of the Global Menopause Market

A growing number of women are looking for non-hormonal therapy to manage menopause symptoms because they are concerned about the possible risks associated with hormone-based treatments. Consequently, there is a growing demand for non-hormonal therapies like CBT, herbal remedies, and mindfulness-based programs.

Telemedicine, internet forums, and smartphone apps are becoming more and more popular for treating menopausal symptoms. These choices offer privacy, comfort, and accessibility, which may be particularly appealing to women who are reluctant to seek medical attention related to menopause.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Menopause Market by Applications

Market Overview
Screening and Diagnosis

Global Menopause Market by End User

Market Overview
Hospital
Diagnostic Centres
Specialty Clinics
Others.

Global Menopause Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TherapeuticsMD Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co. Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis International AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Procter & Gamble Co.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Serenity Pharmaceuticals LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mithra Pharmaceuticals SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments